Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2021 | Arcellx | $120.0M Series C | Samsara BioCapital, CAM Capital | Genoa Ventures, Adage, Asymmetry Ventures, CaaS Capital Management, Cambrian Biopharma, NEA, Novo Holdings, Sixty Degree Capital, SR One, Surveyor Capital, Suvretta Capital Management, Takeda Ventures, Terra Magnum Capital Partners |